Systemic lupus erythematosus with polyarthralgias due to myelofibrosis in a 49-year-old female  by Fechner, A. et al.
Diagnostic and Interventional Imaging (2014) 95, 323—324T
s
g
p
r
T
i
p
i
t
p
b
s
m
o
c
o
m
b
D
TLETTER / Musculoskeletal imaging
Systemic lupus erythematosus
with  polyarthralgias due to
myeloﬁbrosis in a 49-year-old
female
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Systemic  lupus  erythematosus  (SLE)  is  an  autoimmune
disease  with  multiple  complications  in  multiple  organs.
Our  article  is  about  osseous  aspect  of  SLE  myeloﬁbrosis,
which  is  an  infrequent  but  typical  complication.
Observation
A  49-year-old  woman  suffering  from  systemic  lupus  erythe-
matosus  for  the  past  15  years,  treated  by  corticotherapy,
complained  about  chronic  polyarthralgias  during  6  months.
Hematological  state  only  shows  pancytopenia  without  other
abnormalities.  Initial  radiological  evaluation  included  shoul-
der  and  knee  standard  radiographs.  Shoulder  and  knee  MRI
were  also  carried  out  to  complete  the  investigation.
Standard  radiographs  were  taken  on  heterogeneous  spon-
gious  bones,  including  epiphyseal,  metaphyseal,  as  well  as
diaphysal  areas  on  humeral,  acromion,  clavicle,  patellar,
tibial,  and  femoral  bones.  The  lesions  are  mostly  lytic,  mul-
tilocular  (Fig.  1  a  and  b)  with  conservation  (Fig.  1c)  of
some  aspect  of  trabecular  bones  or  sclerosis,  which  appear
laminated.  Endosteal  lysis  below  50%  is  present  (Fig.  1  a).
Figure 1. a: radiographs showing multilocular lytic lesions of the left a
of the knees; c: radiographs showing sclerosis of the pelvic bone. The w
The black asterisks indicate the sclerosis of the bone. The arrows show t
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http://dx.doi.org/10.1016/j.diii.2013.12.004here  is  neither  periosteal  apposition  nor  lesions  in  soft  tis-
ue.
The  MRI  conﬁrms  the  presence  of  several  hetero-
eneous  epiphyseal,  metaphyseal,  and  diaphysal  lesions
resenting  hyposignal  on  T1-weighted  images,  as  well  as
ounded,  well-deﬁned  cystic  lesions  with  hypersignal  on
2-Fat  Sat  weighted  images  (Fig.  2a—c).Their  ﬂuid  level
s  consistent  with  bleeding  lesions.  Furthermore,  there  is
eripheric  enhancement  on  T1  post-gadolinium  weighted
mages  (Fig.  2a—c).  There  is  no  intra-articular  effusion,  and
he  soft  tissue  is  normal.
These  multi-focal  lesions  in  an  SLE  patient  with  isolated
ancytopenia  initially  resemble  multi-focal  bone  myeloﬁ-
rosis.
Renal  and  autoimmune  laboratory  tests  are  normal.  Blood
mear  shows  dacryocytes,  along  with  some  myelocytes  and
etamyelocytes.  Osteomedullar  biopsy  shows  no  presence
f  malignant  cells  (blast  cells)  with  a  decrease  of  global
ells  and  an  increase  of  megakaryocytes.  Argentic  col-
ration  shows  an  increase  of  reticulin  ﬁbers,  consistent  with
edullar  ﬁbrosis.  Therefore,  the  ﬁnal  diagnosis  is  myeloﬁ-
rosis.
iscussion
he  main  cause  of  myeloﬁbrosis  is  the  imbalance  betweennd right humerus, b: radiographs showing multilocular lytic lesions
hite asterisks show the location of the multilocular lytic lesions.
he endosteal lysis.
ollagen  deposition  and  collagen  destruction  by  collagen-
se  [1].  In  SLE  patients,  platelet-derived  growth  factor
PDGF)  and  transforming  growth  factor-  (TGF-) stimu-
ate  collagen  destruction  are  increased  by  autoantibodies
. Published by Elsevier Masson SAS. All rights reserved.
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Figure 2. a: T1 post-gadolinium weighted images showing multilocular lytic lesions of the humerus; b: T2-Fat Sat weighted images showing
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[ultilocular lytic lesions of the knee; c: T1-weighted images showin
sterisks show the location of the cystic lesions.
xed  on  megakaryocytes.  SLE  patients  with  myeloﬁbrosis
how  increased  procollagen  1  and  2  in  serum,  evidence  of
rocollagen  synthesis  by  medullar  ﬁbroblasts  stimulated  by
DGF  and  TGF-. Corticotherapy  has  an  immunosuppressive
ffect,  which  classically  decreases  the  number  of  autoanti-
odies  ﬁxed  on  megakaryocytes,  and  thus,  decreases  ﬁbrosis
2,3].  In  this  case,  despite  corticotherapy  long-term  treat-
ent,  sclerosis  is  really  present  in  radiographs,  representing
he  only  atypical  aspect  of  the  myeloﬁbrosis  under  treat-
ent.
Hematologic  disorders  affect  85%  of  SLE  patients.  How-
ver,  myeloﬁbrosis  is  a  rare  case  of  SLE  pancytopenia  [3—6].
n  most  cases,  chronic  inﬂammatory  autoimmune  anaemia
70%),  thrombopenia  by  anti-phospholipid  syndrome,  or
ypersplenism  is  observed  [7,8].
The  diagnosis  was  conﬁrmed  by  the  pathologist  from  a
one  biopsy.
onclusion
yeloﬁbrosis  is  an  uncommon  complication  of  SLE,  but  the
ypical  radiologic  aspect  needs  to  be  known  to  avoid  misdi-
gnosis.
isclosure  of  interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
eferences
1] Kiss E, Gál I, Simkovics E, Kiss A, Bányai A, Szakáll S, et al.
Myeloﬁbrosis in systemic lupus erythematosus. Leuk Lymphoma
2000;39:661—5.
2] Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myeloﬁ-
brosis: a steroid-responsive cause of bone marrow ﬁbrosisltilocular lytic lesions of the knee. The white arrows and the white
associated with systemic lupus erythematosus. Medicine
1994;73:145—52.
3] Aziz AR, Mohammadian Y, Ruby C, Momin Z, Kumar A, Griciene P,
et al. Systemic lupus erythematosus presenting with pancytope-
nia due to bone marrow myeloﬁbrosis in a 22-year-old male. Clin
Adv Hematol Oncol 2004;2(7):467—9.
4] Feng CS, Ng MH, Szeto RS, Li EK. Bone marrow ﬁndings in lupus
patients with pancytopenia. Pathology 1991;23:5—7.
5] Daly HM, Scott GL. Myeloﬁbrosis as a cause of pancytope-
nia in systemic lupus erythematosus. J Clin Pathol 1983;36:
1219—22.
6] Pereira RM, Velloso ER, Menezes Y, Gualandro S, Vassalo J,
Yoshinari NH. Bone marrow ﬁndings in systemic lupus erythe-
matosus patients with peripheral cytopenias. Clin Rheumatol
1998;17:219—22.
7] Pavithran K, Raji NL, Thomas M. Aplastic anemia complicating
systemic lupus erythematosus: report of a case and review of
the literature. Rhumatology Int 2002;22:253—5.
8] Boumpas DT, Fessler BJ, Austin 3rd HA, Balow JE, Klippel JH,
et al. Systemic lupus erythematosus: emerging concepts; Part
1. Ann Inter Med 1995;122:940—50.
A.  Fechnera,b,  V.  Hummela,
M.  Moustarhﬁra,b,  J.  Manelfea,b,
E.  Schouman-Claeysa,b,  B.  Dallaudièrea,b,c,∗
a Department of radiology, Hôpital universitaire
Bichat, 46, rue Henri-Huchard, 75018 Paris, France
b Université Paris-Diderot, 5, rue Thomas-Mann,
75013 Paris, France
c Inserm U698, Hôpital universitaire Bichat, 46,
rue Henri-Huchard, 75018 Paris, France
∗ Corresponding author. Department of radiology,
Hôpital universitaire Bichat, 46, rue
Henri-Huchard, 75018 Paris, France.
E-mail address: benjamin.dallaudiere@gmail.com
(B. Dallaudière)
